Cipla gets final nod from USFDA for multiple sclerosis drug

Cipla gets final nod from USFDA for multiple sclerosis drug The newly approved product is a generic therapeutic equivalent version of Biogen IDEC Inc's Tecfidera. https://ift.tt/eA8V8J

No comments:

Post a Comment